Antidiabetic drugs such as glyburide, gliclazide, insulin lispro, and insulin glargine are often combined with NSAIDs such as ASA and anticoagulants such as acenocoumarol (the last being dispensed only in our Catalonia data) to treat both conditions, which increases the risk of hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.